Is Evaxion Biotech A/S (EVAX) a Buy, Sell, or Hold?
NASDAQ : EVAX
Evaxion Biotech A/S — Institutional Ownership
$3.1644 USD
$0.06 (2.08%)
- Volume
- 23.82K
- Average Volume
- 25.57K
- Market Capitalization
- $19.99M
- P/E Ratio
- -2.07
- Dividend Yield
- 0.00%
- Price Target
- $9.50
- Year High
- $12.15
- Year Low
- $2.52
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.00
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-05-15 | Armistice Capital, LLC | 310.44K | 4.99% |
| 2025-02-14 | Armistice Capital, LLC | 639.33K | 9.99% |
| 2025-02-03 | Merck & Co., Inc. | 63M | 19.96% |
| 2024-11-14 | Steven Boyd | 555.28K | 9.99% |
| 2024-11-14 | Armistice Capital, LLC | 555.28K | 9.99% |
| 2024-01-23 | Merck Global Health Innovation Fund, LLC | 4.6M | 11.40% |
| 2024-01-23 | Merck & Co., Inc. | 4.6M | 11.40% |
| 2024-01-23 | Merck Sharp & Dohme LLC | 4.6M | 11.40% |
EVAX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $4.77 | 6.41M | $30.57M | $23.23M | $7.5M | $14.84M |
| 2024-12-31 | $4.23 | 1.07M | $4.54M | $5.05M | $10.1M | $9.59M |
| 2023-12-31 | $34.28 | 683.4K | $23.43M | $5.58M | $10.87M | $28.71M |
| 2022-12-31 | $88.75 | 590.97K | $52.45M | $13.18M | $10.26M | $49.52M |
| 2021-12-31 | $221.00 | 487.33K | $107.7M | $32.17M | $3.69M | $79.22M |
| 2020-12-31 | $494.50 | 404.97K | $200.26M | $5.83M | $20000 | $194.44M |
| 2019-12-31 | $494.50 | 404.97K | $200.26M | $9.56M | $36000 | $190.73M |
| 2018-12-31 | $494.50 | 479.97K | $237.34M | $7.43M | $8.67M | $238.58M |
| 2017-12-31 | $494.50 | - | -$ | $468K | $162K | -$306K |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.72 | 8.34M | $31.03M | $18.44M | -$ | $12.59M |
| 2025-12-31 | $4.77 | 6.41M | $30.57M | $23.23M | $7.5M | $14.84M |
| 2025-09-30 | $3.76 | 1.11M | $4.16M | $10.57M | -$ | -$6.42M |
| 2025-06-30 | $2.45 | 1.11M | $2.71M | $14.75M | $11.28M | -$755.14K |
| 2025-03-31 | $1.85 | 1.11M | $2.04M | $17.84M | -$ | -$15.8M |
| 2024-12-31 | $4.23 | 1.07M | $4.54M | $5.05M | $10.1M | $9.59M |
| 2024-09-30 | $15.55 | 1.38M | $21.48M | $4.58M | -$ | $16.9M |
| 2024-06-30 | $14.40 | 1.35M | $19.48M | $7.99M | $10.49M | $21.98M |
| 2024-03-31 | $16.15 | 1.17M | $18.83M | $11.73M | -$ | $7.1M |
| 2023-12-31 | $34.28 | 683.4K | $23.43M | $5.58M | $10.87M | $28.71M |
| 2023-09-30 | $41.65 | 691.5K | $28.8M | $2.6M | $10.31M | $36.5M |
| 2023-06-30 | $65.50 | 676.55K | $44.31M | $7.12M | $10.49M | $47.69M |